|
C11ORF61 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.09899999989338E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.8422999999207E-07 |
| Normal-vs-Stage2 |
1.314010E-02 |
| Normal-vs-Stage3 |
5.5521999999919E-05 |
| Normal-vs-Stage4 |
1.920800E-03 |
| Stage1-vs-Stage2 |
6.759400E-01 |
| Stage1-vs-Stage3 |
5.701600E-01 |
| Stage1-vs-Stage4 |
4.816800E-01 |
| Stage2-vs-Stage3 |
4.879800E-01 |
| Stage2-vs-Stage4 |
8.907600E-01 |
| Stage3-vs-Stage4 |
2.962000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.37700000002461E-06 |
| Normal-vs-AfricanAmerican |
3.58230000000459E-05 |
| Normal-vs-Asian |
2.206200E-02 |
| Caucasian-vs-AfricanAmerican |
9.553600E-02 |
| Caucasian-vs-Asian |
1.543650E-02 |
| AfricanAmerican-vs-Asian |
1.030760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.29059999998127E-06 |
| Normal-vs-Female |
8.21690000041286E-07 |
| Male-vs-Female |
5.641800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.675900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.05859999988134E-07 |
| Normal-vs-Age(61-80Yrs) |
4.34580000000517E-05 |
| Normal-vs-Age(81-100Yrs) |
4.455900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.591400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.049000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.586200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.053600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.900600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.919600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.77330000034659E-07 |
| Normal-vs-Grade 2 |
6.96649999909482E-08 |
| Normal-vs-Grade 3 |
2.64059999999233E-06 |
| Normal-vs-Grade 4 |
1.506830E-01 |
| Grade 1-vs-Grade 2 |
4.839700E-02 |
| Grade 1-vs-Grade 3 |
6.737900E-02 |
| Grade 1-vs-Grade 4 |
8.415500E-03 |
| Grade 2-vs-Grade 3 |
3.352400E-01 |
| Grade 2-vs-Grade 4 |
9.981800E-03 |
| Grade 3-vs-Grade 4 |
3.855700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.90620003010156E-09 |
| Normal-vs-ccB subtype |
6.958100E-03 |
| ccA subtype-vs-ccB subtype |
1.958760E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52795999999178E-05 |
| Normal-vs-N1 |
8.933200E-01 |
| N0-vs-N1 |
1.170450E-01 |
|
|
